Sample size and power calculations for medical studies by simulation when closed form expressions are not available

被引:59
作者
Landau, Sabine [1 ]
Stahl, Daniel [1 ]
机构
[1] Kings Coll London, Inst Psychiat, Dept Biostat, London WC2R 2LS, England
关键词
Monte Carlo simulation; power; precision; missing data; measurement error; causal effect estimation; sensitivity analysis; hybrid approach; CLINICAL-TRIALS; MONTE-CARLO; LONGITUDINAL DESIGNS; STATISTICAL POWER; NO-SHOWS; DICHOTOMIZATION; NONCOMPLIANCE; INTERVENTION; RELIABILITY; DEPRESSION;
D O I
10.1177/0962280212439578
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This paper shows how Monte Carlo simulation can be used for sample size, power or precision calculations when planning medical research studies. Standard study designs can lead to the use of analysis methods for which power formulae do not exist. This may be because complex modelling techniques with optimal statistical properties are used but power formulae have not yet been derived or because analysis models are employed that divert from the population model due to lack of availability of more appropriate analysis tools. Our presentation concentrates on the conceptual steps involved in carrying out power or precision calculations by simulation. We demonstrate these steps in three examples concerned with (i) drop out in longitudinal studies, (ii) measurement error in observational studies and (iii) causal effect estimation in randomised controlled trials with non-compliance. We conclude that the Monte Carlo simulation approach is an important general tool in the methodological arsenal for assessing power and precision.
引用
收藏
页码:324 / 345
页数:22
相关论文
共 65 条
[1]  
Adcock CJ, 1997, J ROY STAT SOC D-STA, V46, P261
[2]   Statistics notes - The cost of dichotomising continuous variables [J].
Altman, DG ;
Royston, P .
BRITISH MEDICAL JOURNAL, 2006, 332 (7549) :1080-1080
[3]  
Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629
[4]  
[Anonymous], 2018, Generalized linear models and extensions
[5]  
Basagana X, 2010, STAT METHODS MED RES, V19, P1
[6]   An introduction to causal modelling in clinical trials [J].
Bellamy, Scarlett L. ;
Lin, Julia Y. ;
Have, Thomas R. Ten .
CLINICAL TRIALS, 2007, 4 (01) :58-73
[7]   ACCOUNTING FOR NO-SHOWS IN EXPERIMENTAL EVALUATION DESIGNS [J].
BLOOM, HS .
EVALUATION REVIEW, 1984, 8 (02) :225-246
[8]   PROJECTION FROM PREVIOUS STUDIES - A BAYESIAN AND FREQUENTIST COMPROMISE [J].
BROWN, BW ;
HERSON, J ;
ATKINSON, EN ;
ROZELL, ME .
CONTROLLED CLINICAL TRIALS, 1987, 8 (01) :29-44
[9]  
Browne W.J., 2009, GUIDE SAMPLE SIZE CA
[10]   Developments in cluster randomized trials and Statistics in Medicine [J].
Campbell, M. J. ;
Donner, A. ;
Klar, N. .
STATISTICS IN MEDICINE, 2007, 26 (01) :2-19